Sort
21,453 grants matching “tuberculosis”
Core E Animal Infection Models
$941,758David S Perlin · Hackensack University Medical Center · U19 · FY2019 · AI
Novel rifamycins to improve cure rates and shorten treatment of M. abscessus lung disease
$941,394Thomas Dick · Hackensack University Medical Center · U19 · FY2025 · AI
Development of novel proteins synthesis inhibitors for MDR tuberculosis
$940,979Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2011 · AI
Immunotherapeutics and vaccines against anthrax, plague and tularemia
$940,978Zheng W Chen · University Of Illinois At Chicago · U01 · FY2009 · AI
Immunotherapeutics and vaccines against anthrax, plague and tularemia
$940,299Zheng W Chen · University Of Illinois At Chicago · U01 · FY2006 · AI
A micronized electrostatic precipitator for next-generation respiratory protection against pathogenic aerosols
$940,026Julian Henley · Henley Ion, Llc · R44 · FY2023 · AI
IAS 2025. the 13th IAS Conference on HIV Science, Kigali, Rwanda, 14-17 July 2025
$940,000Chris Beyrer · Ias · R13 · FY2025 · AI
RP3: Targeting ATG gene-dependent immunity for novel anti-infective therapeutics
$939,459Seungmin Hwang · Ut Southwestern Medical Center · U19 · FY2023 · AI
Optimization and Advanced Proof-of-Concept Studies of a Listeria-vectored Multi-Antigenic Vaccine against Tuberculosis
$939,379Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2019 · AI
UCB/UCSF AIDS International Training and Research Program (AITRP)
$939,335Arthur L. Reingold · University Of California Berkeley · D43 · FY2010 · TW
M. tuberculosis carbon metabolism during infection
$939,332Sabine Ehrt · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AI
Advanced Mass Spectrometry Facility
$938,947David Anderson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2009 · DK
Discovery and validation of drug resistance mutations
$938,261Eric H. Rubin · Harvard Medical School · U19 · FY2018 · AI
Gene Regulation In The Immune System
$937,804Keiko Ozato · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2013 · HD
PS05-003 TUBERCULOSIS ELIMINATION AND LABORATORY
$937,658Karyn L Berry · District Of Columbia Dept Of Human Srvs · U52 · FY2007 · PS
Microsensor Arrays for Saliva Diagnostics
$937,339Tufts University Medford · U01 · FY2003 · DE
Clinical Core
$936,892Daniel W Fitzgerald · Weill Medical Coll Of Cornell Univ · U19 · FY2015 · AI
Development of novel proteins synthesis inhibitors for MDR tuberculosis
$936,466Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2013 · AI
Safety and Tolerability of Ultra-short Course Rifapentine and Isoniazid (1HP) for Prevention of Tuberculosis in HIV-Uninfected Individuals
$936,265Richard E Chaisson · Johns Hopkins University · U01 · FY2021 · AI
Microsensor Arrays for Saliva Diagnostics
$935,857Tufts University Medford · U01 · FY2004 · DE
Immune Determinants of the Course of Mycobacterium tuberculosis infection and Disease
$935,638Padmini Salgame · Rutgers Biomedical And Health Sciences · U19 · FY2024 · AI
New anti-tubercular agents targeting intracellular bacteria
$935,324Tanya Parish · Seattle Children'S Hospital · R01 · FY2024 · AI
Efficacy and Safety of AI-enabled PRS Regimen VI (Clofazimine, Bedaquiline and Pyrazinamide) as Ultra-Short Course Therapy of LTBI in Non-Human Primates in a setting mimicking HIV co-infection
$934,898Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2024 · AI
TRAINING AND RESEARCH IN HIV PREVENTION IN RUSSIA
$934,129Yale University · D43 · FY2003 · TW
Core 1: Facility Management, Maintenance and Operations Core
$933,206Colin S. Duckett · Duke University · UC7 · FY2023 · AI